It was another busy week for Australia’s top brokers. This has led to the release of a number of broker notes.
Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think these ASX shares are in the buy zone:
Guzman Y Gomez Ltd (ASX: GYG)
According to a note out of Morgans, its analysts have retained their buy rating on this burrito seller’s shares with an improved price target of $26.70. Morgans was pleased with the company’s third-quarter update last week. It highlights that Guzman Y Gomez delivered a meaningful acceleration in Australian comparable store sales growth. It believes this provides tangible evidence that the business is executing well against a challenging consumer backdrop. In addition, Morgans points out that transaction growth continued to outpace comparable store sales growth. This maintains the company’s growth strategy to be volume and frequency-led rather than price-driven. The Guzman Y Gomez share price ended the week at $20.68.
Lovisa Holdings Ltd (ASX: LOV)
A note out of UBS reveals that its analysts have upgraded this fashion jewellery retailer’s shares to a buy rating with a $26.00 price target. UBS points out that Lovisa’s shares have fallen heavily this year. This has been driven by concerns over slower store growth, softer like-for-like sales in the Australian market, and ongoing losses from the new Jewells store brand. However, the broker believes much of this is now priced in. Furthermore, it believes the resilience of Lovisa’s youth-focused, low price point offering is underappreciated by the market, and expects management to prevent sustained losses from Jewells. This will be by either fixing the business or considering a closure. The Lovisa share price was fetching $23.32 at Friday’s close.
Sigma Healthcare Ltd (ASX: SIG)
Analysts at Morgans have upgraded this pharmacy chain operator and wholesale distributor’s shares to a buy rating with a $3.36 price target. According to the note, the broker is forecasting Sigma to deliver strong earnings growth over the medium term. This is expected to be supported by same store sales growth, store rollouts, and synergies from the Chemist Warehouse merger. In light of this and recent share price weakness, Morgans sees now as a good time to invest. The Sigma Healthcare share price ended the week at $2.69.
The post Top brokers name 3 ASX shares to buy next week appeared first on The Motley Fool Australia.
Should you invest $1,000 in Guzman Y Gomez right now?
Before you buy Guzman Y Gomez shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Guzman Y Gomez wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Buy, hold, sell: Life360, Northern Star, and Sigma shares
- Brokers name 3 ASX shares to buy right now
- Broker sees 26% upside in ASX healthcare share behind Chemist Warehouse
- 3 ASX 200 stocks surging 13% to 36% in this shortened trading week
- Got $7,500? Here are 2 strong ASX retail stocks to buy now
Motley Fool contributor James Mickleboro has positions in Lovisa. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa. The Motley Fool Australia has recommended Lovisa. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.